Cited by 57Stress Responses and CortisolAdrenal Hormones and DisordersRegulation of Appetite and Obesity

Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.

Schwartz, Michael W, Strack, Alison M, Dallman, Mary F·1997·Regulatory Peptides

Abstract

Uncontrolled diabetes mellitus causes both a sustained activation of the hypothalamic-pituitary-adrenal (HPA) axis and reduced expression of corticotrophin-releasing hormone (CRH) mRNA in the hypothalamic paraventricular nucleus (PVN). To investigate the role of glucocorticoids in the regulation of CRH mRNA expression in the PVN of diabetic rats, we studied surgically adrenalectomized (ADX) and sham-operated male Sprague-Dawley rats 4 days after i.v. injection of streptozotocin (STZ; 65 mg/kg i.v.) or vehicle. Among sham-operated animals, AM plasma corticosterone levels were significantly increased in diabetic as compared to nondiabetic animals (1.46+/-0.54 vs. 0.22+/-0.05 microg/dl; P <0.05), and were positively correlated to both plasma ACTH levels (r = 0.74; P = 0.015) and adrenal gland weight (r = 0.70; P = 0.025). In contrast, CRH mRNA levels measured in the PVN by in situ hybridization were inversely related to the plasma corticosterone level (r = -0.68; P = 0.045). In a second experiment, both diabetic and nondiabetic ADX rats received a continuous subcutaneous infusion of either corticosterone at one of two doses or its vehicle for 4 days. Among vehicle-treated ADX animals, STZ diabetes raised hypothalamic CRH mRNA levels, in contrast to the tendency for diabetes to lower CRH mRNA in intact rats in the first experiment. Corticosterone administration lowered CRH mRNA comparably in both diabetic and nondiabetic ADX rats. In contrast, diabetes reduced arginine vasopressin (AVP) mRNA levels in the PVN of ADX rats and blunted the inhibitory effect of glucocorticoids on AVP mRNA levels in this setting. We conclude (1) glucocorticoids are necessary for the effect of diabetes to reduce hypothalamic CRH gene expression, since diabetes causes a paradoxical increase in CRH mRNA levels in adrenalectomized animals; (2) glucocorticoid inhibition of hypothalamic CRH gene expression is intact in diabetic rats; and (3) the activation of the HPA axis by diabetes is associated with a proportionate decrease in PVN CRH gene expression. These findings support a model in which hypothalamic factors additional to CRH activate the HPA axis in uncontrolled diabetes, and inhibit CRH gene expression indirectly by negative glucocorticoid feedback.

Integrity signals

Registry

Crossref · 10.1016/s0167-0115(97)01043-4

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schwartz, M. W., Strack, A. M., & Dallman, M. F.
Affiliations
  • United States Department of Veterans Affairs (US)
  • University of California, San Francisco (US)
Corresponding author
Schwartz, Michael W
Venue
Regulatory Peptides
Publisher
Elsevier BV
Published
1997-10
Volume
72
Issue
2-3
Pages
105-112
ISSN
0167-0115 (ISSN-L)
OpenAlex
W2053027732
Cited by
57
References
28
Citations by year
2022: 1 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 5 · 2013: 2
FWCI
1.61
Type
journal article
Language
en
Open access
closed
Locations
  • Regulatory Peptides (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK17844, DK28172)
  • National Institute of Neurological Disorders and Stroke (NS-32273)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
diabetes mellitus, corticosterone, glucocorticoids, corticotropin-releasing factor, CRH gene expression, hypothalamic paraventricular nucleus, hypothalamic-pituitary-adrenal axis, adrenalectomy, streptozotocin-induced diabetes, vasopressin, ACTH, glucocorticoid feedback inhibition
MeSH terms
Adrenal Glands, Adrenalectomy, Animals, Arginine Vasopressin, Corticosterone, Corticotropin-Releasing Hormone, Diabetes Mellitus, Experimental, Gene Expression Regulation, Hypothalamus, Male, Neuropeptides, Organ Size, Paraventricular Hypothalamic Nucleus, Pituitary-Adrenal System, RNA, Messenger, Streptozocin, Rats, Sprague-Dawley, In Situ Hybridization, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review